Simtuzumab Completed Phase 2 Trials for Hepatitis C Viral Infection / Human Immunodeficiency Virus (HIV) Infections / Hepatitis C Infection With HIV Co-Infection / Fibrosis, Liver Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01707472Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis